Literature DB >> 7758157

Cardiac troponin I phosphorylation increases the rate of cardiac muscle relaxation.

R Zhang1, J Zhao, A Mandveno, J D Potter.   

Abstract

Cardiac troponin (Tn) I (CTnI), compared with skeletal TnI, contains extra amino acids (32 to 33) at its amino terminus, including two adjacent serine residues. These two serine residues are believed to be phosphorylated by protein kinase A (PKA) upon stimulation of the heart by beta-agonists. In this study, we found that phosphorylation of a cardiac skinned muscle preparation by PKA, mainly at CTnI, results in a decrease in the Ca2+ sensitivity of muscle contraction. The pCa50 decreased by approximately 0.27 +/- 0.06 pCa units upon phosphorylation. To study cardiac muscle relaxation, we used diazo-2, a photolabile Ca2+ chelator with a low Ca2+ affinity in its intact form that is converted to a high-affinity form after photolysis. We found that the rate of cardiac muscle relaxation increased from a time of half-relaxation (t1/2) = 110 +/- 10 milliseconds to t1/2 = 70 +/- 8 milliseconds after CTnI phosphorylation. This result demonstrates that CTnI phosphorylation can be linked with the increased rate of muscle relaxation in a relatively intact muscle preparation. Since CTnI phosphorylation has been shown previously to affect the Ca2+ affinity and Ca2+ off-rate of CTnC in vitro, it is likely that the faster relaxation seen here reflects faster dissociation of Ca2+ from cardiac TnC (CTnC). Model calculations show that increased dissociation of Ca2+ from CTnC, coupled with the faster uptake of Ca2+ by the sarcoplasmic reticulum stimulated by PKA phosphorylation of phospholamban, can account for the faster relaxation seen in the inotropic response of the heart to catecholamines.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7758157     DOI: 10.1161/01.res.76.6.1028

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  115 in total

1.  Putative beta 4-adrenoceptors in rat ventricle mediate increases in contractile force and cell Ca2+: comparison with atrial receptors and relationship to (-)-[3H]-CGP 12177 binding.

Authors:  D Sarsero; P Molenaar; A J Kaumann; N S Freestone
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

2.  Elementary steps of the cross-bridge cycle in bovine myocardium with and without regulatory proteins.

Authors:  Hideaki Fujita; Daisuke Sasaki; Shin'ichi Ishiwata; Masataka Kawai
Journal:  Biophys J       Date:  2002-02       Impact factor: 4.033

3.  Force relaxation and thin filament protein phosphorylation during acute myocardial ischemia.

Authors:  Young Soo Han; Ozgur Ogut
Journal:  Cytoskeleton (Hoboken)       Date:  2010-11-02

4.  Decreased polycystin 2 expression alters calcium-contraction coupling and changes β-adrenergic signaling pathways.

Authors:  Ivana Y Kuo; Andrea T Kwaczala; Lily Nguyen; Kerry S Russell; Stuart G Campbell; Barbara E Ehrlich
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-03       Impact factor: 11.205

5.  Myofilament-based relaxant effect of isoprenaline revealed during work-loop contractions in rat cardiac trabeculae.

Authors:  Joanne Layland; Jonathan C Kentish
Journal:  J Physiol       Date:  2002-10-01       Impact factor: 5.182

6.  Roles of phosphorylation of myosin binding protein-C and troponin I in mouse cardiac muscle twitch dynamics.

Authors:  Carl W Tong; Robert D Gaffin; David C Zawieja; Mariappan Muthuchamy
Journal:  J Physiol       Date:  2004-06-11       Impact factor: 5.182

7.  Hyperphosphorylation of the cardiac ryanodine receptor at serine 2808 is not involved in cardiac dysfunction after myocardial infarction.

Authors:  Hongyu Zhang; Catherine A Makarewich; Hajime Kubo; Wei Wang; Jason M Duran; Ying Li; Remus M Berretta; Walter J Koch; Xiongwen Chen; Erhe Gao; Héctor H Valdivia; Steven R Houser
Journal:  Circ Res       Date:  2012-02-02       Impact factor: 17.367

8.  Functional characterization of TNNC1 rare variants identified in dilated cardiomyopathy.

Authors:  Jose Renato Pinto; Jill D Siegfried; Michelle S Parvatiyar; Duanxiang Li; Nadine Norton; Michelle A Jones; Jingsheng Liang; James D Potter; Ray E Hershberger
Journal:  J Biol Chem       Date:  2011-08-05       Impact factor: 5.157

9.  Desensitization of myofilaments to Ca2+ as a therapeutic target for hypertrophic cardiomyopathy with mutations in thin filament proteins.

Authors:  Marco L Alves; Fernando A L Dias; Robert D Gaffin; Jillian N Simon; Eric M Montminy; Brandon J Biesiadecki; Aaron C Hinken; Chad M Warren; Megan S Utter; Robert T Davis; Sadayappan Sakthivel; Jeffrey Robbins; David F Wieczorek; R John Solaro; Beata M Wolska
Journal:  Circ Cardiovasc Genet       Date:  2014-02-28

10.  Cardiac troponin T mutations: correlation between the type of mutation and the nature of myofilament dysfunction in transgenic mice.

Authors:  D E Montgomery; J C Tardiff; M Chandra
Journal:  J Physiol       Date:  2001-10-15       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.